Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The fibrinolytic system is part of the defense against thrombotic and cardiovascular events, but so far no study has shown that clinical measurements of fibrinolytic key components such as tissue plasminogen activator (t-PA) or plasminogen activator inhibitor type 1 (PAI-1) have any predictive value beyond 3 years. METHODS AND RESULTS: In 1983 through 1985, 213 consecutive patients with angina pectoris and angiographically verified coronary artery disease were sampled, and the mass concentration of t-PA and the activity of PAI-1 were measured in citrated plasma samples. At a mean follow-up time of 7 years, the all-cause mortality was checked. No patient was lost to follow-up. The data were analyzed by Cox regression, and t-PA mass concentration was found to be the only laboratory risk factor significantly related to mortality in all patients (P < .022) and also in the major subgroup (78% of all patients) subjected to coronary bypass surgery (P < .027). In the latter subgroup, body mass index was also related to mortality. CONCLUSIONS: An increased mass concentration of t-PA is a new risk factor of long-term mortality in patients with angina pectoris and coronary artery stenosis. This paradoxical effect probably reflects increased t-PA levels attributable to enzyme inhibitor complex formation in subjects with increased plasma levels of t-PA inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Endogenous tissue-type plasminogen activator and risk of myocardial infarction
Ridker, P. M., Vaughan, D. E., Manson, J., Hennekens, C., & Stampfer, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)90998-v · Cited by 582
Juhan-Vague, I., Alessi, M. C., & Vague, P. (1991) · Diabetologia · doi:10.1007/bf00403280 · Cited by 567
Synthesis of fibrinolytic activator and inhibitor by endothelial cells
Loskutoff, D. J., & Edgington, T. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3903 · Cited by 479
Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
Chmielewska, J., Rånby, M., & Wiman, B. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90407-3 · Cited by 469
OOLOFESSON, B. O., DAHLÈN, G., & NILSSON, T. K. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059384 · Cited by 224
Self-citationRånby, M., Bergsdorf, N., Nilsson, T., Mellbring, G., Winblad, B., & Bucht, G. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.12.2160 · Cited by 192
Self-citationDetermination of tissue plasminogen activator and its "fast" inhibitor in plasma.
Chmielewska, J., & Wiman, B. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.3.482 · Cited by 183
JANSSON, J. H., NILSSON, T. K., & OLOFSSON, B. O. (1991) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059862 · Cited by 172
Self-citation
Cited by
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Thögersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., & Hallmans, G. (1998) · Circulation · doi:10.1161/01.cir.98.21.2241 · Cited by 602
Self-citationJuhan-Vague, I., Pyke, S. D. M., Alessi, M. C., Jespersen, J., Haverkate, F., & Thompson, S. G. (1996) · Circulation · doi:10.1161/01.cir.94.9.2057 · Cited by 552
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
Price, J. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1194 · Cited by 396
Newby, D. E., Wright, R. A., Labinjoh, C., Ludlam, C. A., Fox, K. A. A., Boon, N. A., & Webb, D. J. (1999) · Circulation · doi:10.1161/01.cir.99.11.1411 · Cited by 382
Obesity, haemostasis and the fibrinolytic system
Mertens, I., & Gaal, L. F. V. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00056.x · Cited by 368
Hemostatic Factors as Predictors of Ischemic Heart Disease and Stroke in the Edinburgh Artery Study
Smith, F. B., Lee, A. J., Fowkes, F. G. R., Price, J. F., Rumley, A., & Lowe, G. D. O. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.3321 · Cited by 351
Pleiotropic functions of plasminogen activator inhibitor-1
LIJNEN, H. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00827.x · Cited by 312
Gebara, O. C. E., Mittleman, M. A., Sutherland, P., Lipinska, I., Matheney, T., Xu, P., Welty, F. K., Wilson, P. W. F., Levy, D., Muller, J. E., et al. (1995) · Circulation · doi:10.1161/01.cir.91.7.1952 · Cited by 298
Association of Fibrinolytic Parameters With Early Atherosclerosis: The ARIC Study
Salomaa, V., Stinson JD, V., Kark, J. D., Folsom, A. R., Davis, C. E., & Wu, K. K. (1995) · Circulation · doi:10.1161/01.cir.91.2.284 · Cited by 286
Chandler, W. L., Alessi, M. C., Aillaud, M. F., Henderson, P., Vague, P., & Juhan-Vague, I. (1997) · Circulation · doi:10.1161/01.cir.96.3.761 · Cited by 245
Oxidative risk for atherothrombotic cardiovascular disease
Leopold, J. A., & Loscalzo, J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.009 · Cited by 215
Shadows of complexity: what biological networks reveal about epistasis and pleiotropy
Tyler, A. L., Asselbergs, F. W., Williams, S. M., & Moore, J. H. (2009) · BioEssays · doi:10.1002/bies.200800022 · Cited by 185
Novel Risk Factors for Atherosclerosis
Kullo, I. J., Gau, G. T., & Tajik, A. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.369 · Cited by 161
Minai, K., Matsumoto, T., Horie, H., Ohira, N., Takashima, H., Yokohama, H., & Kinoshita, M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01202-5 · Cited by 86
Metadata
- Authors
- Jansson, J. H., Olofsson, B. O., & Nilsson, T. K.
- Venue
- Circulation
- Published
- 1993-11
- Volume
- 88
- Issue
- 5
- Pages
- 2030-2034
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2024991598
- Cited by
- 240
- References
- 14
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.